Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × Bortezomib × Clear all

NCT00068289 2013-06-24

Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma